Dr. Reddy’s Laboratories Ltd ADR annual operating income for fiscal TTM was ₹35.2 billion, a decrease of 28.0% from ₹48.9 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.
| Operating Income (annual) | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | 2011-03-31 | 2010-03-31 | 2009-03-31 | 2008-03-31 | 2007-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | ₹35.2B | ₹48.9B | ₹71.8B | ₹67.7B | ₹57.1B | ₹29.5B | ₹431M | ₹16.0B | ₹20.9B | ₹11.9B | ₹13.5B | ₹29.6B | ₹26.3B | ₹26.0B | ₹21.1B | ₹18.3B | ₹12.6B | ₹2.0B | (₹2.8B) | ₹3.4B | ₹11.3B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Operating Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | ₹3.0B | ₹473M | ₹14.2B | ₹17.5B | ₹17.5B | ₹17.6B | ₹18.7B | ₹17.6B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More RDY metrics: Revenue · Gross Profit · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All RDY financial statements → Interactive RDY charts →
About TickerBase · Data methodology & sources · Privacy · Terms